Table 1 Association of CircMUC16 expression with clinicopathological characteristics in 70 patients of EOC
From: CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a
No. of patients | CircMUC16 expression | P value | ||
|---|---|---|---|---|
(n = 100) | Low no.(%) | High no.(%) | ||
Characteristics | ||||
Age (years) | > 0.05 | |||
< 50 | 48 | 23(47.92%) | 25(52.08%) | |
≥ 50 | 52 | 24(46.15%) | 28(53.85%) | |
Normal ovarian | 30 | 28(93.33%) | 2(6.67%) | < 0.05 |
Cancer tissues | 70 | 19(27.14%) | 51(72.86%) | |
FIGO stage | ||||
I/II | 40 | 15(37.50%) | 25(62.50%) | < 0.05 |
III/IV | 30 | 4(13.33%) | 26(86.67%) | |
Grade | ||||
1 | 16 | 12(75.00%) | 4(25.00%) | |
2 | 21 | 5(23.81%) | 16(76.19%) | |
3 | 33 | 2(6.06%) | 31(93.94%) | |
Grade 2–3 versus 1 | < 0.05 | |||